Supply of Sofosbuvir 400 mg/Daclatasvir 60 mg to Cambodia
UNOPS
Supply of Sofosbuvir 400 mg/Daclatasvir 60 mg to Cambodia
Invitation to bid
Reference:
ITB/2024/53757
Beneficiary countries or territories:
Cambodia
Registration level:
Basic
Published on:
20-Sep-2024
Deadline on:
07-Oct-2024 05:00 0.00
Description
The goods include Supply of Sofosbuvir 400 mg/Daclatasvir 60 mg to Cambodia as further described in Section II: Schedule of Requirements of this ITB.
-----
IMPORTANT NOTE: Interested vendors must respond to this tender using the UNOPS eSourcing system, via the UNGM portal. In order to access the full UNOPS tender details, request clarifications on the tender, and submit a vendor response to a tender using the system, vendors need to be registered as a UNOPS vendor at the UNGM portal and be logged into UNGM. For guidance on how to register on UNGM and submit responses to UNOPS tenders in the UNOPS eSourcing system, please refer to the vendor user guide attached in the Documents tab of this tender or on the Links tab of the UNGM tender notice.
-----
IMPORTANT NOTE: Interested vendors must respond to this tender using the UNOPS eSourcing system, via the UNGM portal. In order to access the full UNOPS tender details, request clarifications on the tender, and submit a vendor response to a tender using the system, vendors need to be registered as a UNOPS vendor at the UNGM portal and be logged into UNGM. For guidance on how to register on UNGM and submit responses to UNOPS tenders in the UNOPS eSourcing system, please refer to the vendor user guide attached in the Documents tab of this tender or on the Links tab of the UNGM tender notice.
This tender has been posted through the UNOPS eSourcing system. / Cet avis a été publié au moyen du système eSourcing de l'UNOPS. / Esta licitación ha sido publicada usando el sistema eSourcing de UNOPS. Vendor Guide / Guide pour Fournisseurs / Guíra para Proveedores: https://esourcing.unops.org/#/Help/Guides
First name:
N/A
Surname:
N/A
This procurement opportunity integrates considerations for at least one sustainability indicator. However, it does not meet the requirements to be considered sustainable.
Human rights and labour issues
Social
The tender contains sustainability considerations related to human rights, fundamental principles and rights at work, occupational health and safety, fairly traded goods, targeted employment of people with disabilities, etc.
Link | Description | |
---|---|---|
https://esourcing.unops.org/#/Help/Guides | UNOPS eSourcing – Vendor guide and other system resources / Guide pour fournisseurs et autres ressources sur le système / Guía para proveedores y otros recursos sobre el sistema |
51341501
-
Amprenavir
51341604
-
Rimantadine hydrochloride
51341801
-
Darunavir
51341802
-
Oseltamivir
51341803
-
Darunavir ethanolate
51341805
-
Oseltamivir phosphate
51341806
-
Sofosbuvir
51341807
-
Daclatasvir
51341901
-
Zanamivir
51341903
-
Efavirenz
51341904
-
Maraviroc
51342301
-
Valaciclovir or valacyclovir
51342304
-
Entecavir
51342305
-
Ganciclovir
51342307
-
Penciclovir
51342308
-
Valganciclovir
51342309
-
Aciclovir or acyclovir
51342310
-
Valacyclovir hydrochloride
51342311
-
Aciclovir sodium
51342313
-
Ganciclovir sodium
51342316
-
Valganciclovir hydrochloride
51342402
-
Saquinavir
51342501
-
Abacavir
51342503
-
Ribavirin
51342506
-
Abacavir sulfate
51342701
-
Atazanavir
51342702
-
Enfuvirtide
51342709
-
Interferon beta-1a
51342710
-
Interferon beta-1b
51342715
-
Peginterferon alfa-2a
51342901
-
Didanosine
51342902
-
Famciclovir
51342904
-
Vidarabine
51343002
-
Nevirapine
51343004
-
Stavudine or stavidine
51343005
-
Stavudine and lamivudine and nevirapine
51343101
-
Idoxuridine
51343110
-
Lamivudine
51343115
-
Zalcitabine
51343116
-
Azidothymidine or zidovudine
51343201
-
Raltegravir
51343203
-
Ritonavir
51343204
-
Dolutegravir
51343502
-
Cidofovir
51343509
-
Tenofovir alafenamide fumarate
51343511
-
Tenofovir disoproxil
51343702
-
Moroxydine
51343704
-
Etravirine
51343801
-
Abacavir/lamivudine
51343803
-
Efavirenz/emtricitabine/tenofovir
51343804
-
Emtricitabine/tenofovir
51343806
-
Lamivudine/zidovudine
51343809
-
Dolutegravir/Abacavir/Lamivudine
51343810
-
Darunavir/Cobicistat
51343811
-
Emtricitabine/Tenofovir Alafenamide/Bictegravir
51343811
-
Emtricitabine/Tenofovir Alafenamide/Bictegravir
51343812
-
Glecaprevir/Pibrentasvir
51343813
-
Sofosbuvir/Velpatasvir
51343814
-
Lopinavir/ritonavir
51343816
-
Lamivudine/tenofovir DF
51343820
-
Lamivudine/nevirapine/zidovudine
51343821
-
Lopinavir/ritonavir
51343822
-
Atazanavir/ritonavir
51343826
-
Sofosbuvir/Velpatasvir
51343827
-
Daclatasvir/Sofosbuvir
51343828
-
Darunavir/Ritonavir
New amendment added #1: This amendment is made for this ITB as per the followings;1. Revised "Section III_Returnable Bidding Forms_ITB_2024_53757_Amendment I" is added please refer to this form for submission2. Qualification for Sustainability is updated
Edited on:
26-Sep-2024 09:43
Edited by:
webservice@unops.org
New clarification added: Q: Regarding the requested product , we do not have combination of Sofosbuvir 400mg and Daclatasvir 60mg but we have individual products. Please confirm if we can quote Sofosbuvir 400mg and Daclatasvir 60mg individually.A: Dear Supplier,Please quote the available product from your stock range that meets with the technical specifications mentioned in the tender document.Best Regards,UNOPS
Edited on:
25-Sep-2024 03:47
Edited by:
webservice@unops.org